Budesonide/formoterol is a combination medication used for the long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: budesonide, a corticosteroid that reduces inflammation in the airways, and formoterol, a long-acting beta agonist that helps relax the muscles in the airways to improve airflow. Budesonide/formoterol is available in inhalation aerosol and dry powder inhaler formulations, providing rapid and sustained relief from symptoms of asthma and COPD.

One of the standout features of budesonide/formoterol is its dual mechanism of action, which targets both the inflammation and bronchoconstriction associated with asthma and COPD. By reducing airway inflammation and bronchospasm, it helps improve lung function and reduce the frequency and severity of asthma attacks and COPD exacerbations. Additionally, budesonide/formoterol offers the convenience of combination therapy in a single inhaler device, simplifying medication management and ensuring optimal delivery of both medications to the lungs.